Evaluating the Outcomes of Active Surveillance in Grade Group 2 Prostate Cancer: Prospective Results from the Canary PASS Cohort. Letter.

MLA

Wang, Michael, et al. “Evaluating the Outcomes of Active Surveillance in Grade Group 2 Prostate Cancer: Prospective Results from the Canary PASS Cohort. Letter.” The Journal of Urology, vol. 207, no. 5, May 2022, pp. 1160–61. EBSCOhost, https://doi.org/10.1097/JU.0000000000002442.

APA

Wang, M., Semerjian, A., Lane, B. R., George, A. K., & Ginsburg, K. B. (2022). Evaluating the Outcomes of Active Surveillance in Grade Group 2 Prostate Cancer: Prospective Results from the Canary PASS Cohort. Letter. The Journal of Urology, 207(5), 1160–1161. https://doi.org/10.1097/JU.0000000000002442

Chicago

Wang, Michael, Alice Semerjian, Brian R Lane, Arvin K George, and Kevin B Ginsburg. 2022. “Evaluating the Outcomes of Active Surveillance in Grade Group 2 Prostate Cancer: Prospective Results from the Canary PASS Cohort. Letter.” The Journal of Urology 207 (5): 1160–61. doi:10.1097/JU.0000000000002442.